Item 7.01 Regulation FD Disclosure.

On September 2, 2021, Keros Therapeutics, Inc. (the "Company") issued a press release announcing that Jasbir Seehra, the Company's President and Chief Executive Officer, will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10 at 11:00 am ET and in the H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, starting at 7:00 am ET. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.




Item 9.01   Financial Statements and Exhibits.
(d) Exhibits

Exhibit No.                    Description
  99.1                           Press release dated     September 2    , 2021.
                               Cover Page Interactive Data File (the cover page XBRL tags are
104                            embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses